Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
09/2005
09/07/2005EP1328519B1 Orally active salts with tyrosine kinase activity
09/07/2005EP1289953B1 Serine protease inhibitors
09/07/2005EP1280801B1 Hydantoin-containing glucokinase activators
09/07/2005EP1254133B9 Indol-3-yl derivatives and their use as integrin inhibitors
09/07/2005EP1214314B1 Aminopiperidine derivatives as antibacterials
09/07/2005EP1192132B1 Serine protease inhibitors
09/07/2005EP1189893B1 Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)one
09/07/2005EP1188747B1 Phenoxypropylamine compounds
09/07/2005EP1187812B1 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors
09/07/2005EP1042295B1 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
09/07/2005EP1037634B1 Oral administration form comprising a proton pump inhibitor (e.g.pantoprazole)
09/07/2005EP0888310B1 Cinnoline derivatives and use as medicine
09/07/2005CN1666577A Electronic devices made with electron transport and/or anti-quenching layers
09/07/2005CN1666357A Polymeric charge transport compositions and electronic devices made with such compositions
09/07/2005CN1665806A Medicine compound
09/07/2005CN1665805A Method for preparing optical purity or optically concentrated sulfoxide compounds comprising amorphous esomeprazole and its salts
09/07/2005CN1665804A 4, 4-disubstituted piperidine derivatives having CCR3 antagonism
09/07/2005CN1665792A Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses
09/07/2005CN1665791A Quinazoline derivatives
09/07/2005CN1665789A Diaminopyrimidinecarboxa mide derivative
09/07/2005CN1665787A Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
09/07/2005CN1665786A Secondary amino anilinic piperidines as MCH1 antagonists and uses thereof
09/07/2005CN1665785A 2-cyano-4-fluoropyrrolidine derivative or its salt
09/07/2005CN1665784A Peptide inhibitors of SMAC protein binding to inhibitor of apoptosis proteins (IAP)
09/07/2005CN1665780A Tricyclic steroid hormone nuclear receptor modulators
09/07/2005CN1665506A 2, 5-substituted pyrimidine derivatives as CCR-3 receptor antagonists IX
09/07/2005CN1665505A 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating pulmonary fibrosis
09/07/2005CN1665504A Novel crystalline forms of gatifloxacin
09/07/2005CN1665502A MCHIR antagonists
09/07/2005CN1665501A Novel compounds as opioid receptor modulators
09/07/2005CN1665395A Synergistic fungicide compositions containing at least one N-(2-pyridinyl) 1-3-pyridinecarboxamide derivative and one or more further fungicides useful for controlling fungal plant diseases
09/07/2005CN1663952A Preparation of quinoline-substituted carbonate and carbamate derivatives
09/07/2005CN1217936C Heterocyclic compounds having sulfonamide
09/07/2005CN1217934C Prepn. of quinoline-substituted carbonate and carbamate derivatives
09/07/2005CN1217932C Antibacterial agents
09/06/2005US6939971 (R)-2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2 -pyridinyl)methyl)sulfinyl)-1H-benzimidazole, (R(+)-lansoprazole); antiulcer agent
09/06/2005US6939883 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
09/06/2005US6939882 Fungicides
09/06/2005US6939874 Substituted pyrimidinyl derivatives and methods of use
09/06/2005US6939870 Heterocyclic amines such as 3-[2-(4-(1H-indol-3-yl)-3,6-dihydro-1(2H)-pyridinyl)ethyl]-6-7-dimethoxy-4(3H)-quinazolinone, used as antidepressants or anxiolytic agents for prophylaxis of psychological disorders
09/06/2005US6939867 Phenyl sulfamide derivatives as dietetics, antidiabetics, and hypotensive agents
09/01/2005WO2005080403A2 Chemical process
09/01/2005WO2005080394A1 4-substituted piperidine derivatives
09/01/2005WO2005080388A1 Viral polymerase inhibitors
09/01/2005WO2005080386A1 Polyheterocyclic compounds and their use as metabotropic glutamate receptor antagonists
09/01/2005WO2005080382A1 Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
09/01/2005WO2005080379A1 Triazole compounds and their use as metabotropic glutamate receptor antagonists
09/01/2005WO2005080378A1 Fused pyridazine derivatives
09/01/2005WO2005080377A1 COMPOUND HAVING TGF-β INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
09/01/2005WO2005080376A1 Substituted spiro azabicyclics as modulators of chemokine receptor activity
09/01/2005WO2005080375A1 Crystalline form of a biphenyl compound
09/01/2005WO2005080374A1 New compounds useful for the synthesis of s- and r-omeprazole and a process for their preparation
09/01/2005WO2005080373A1 Substituted quinoline compounds
09/01/2005WO2005080372A1 Dihydropyridinone derivatives
09/01/2005WO2005080371A1 Amino heterocyclic modulators of chemokine receptor activity
09/01/2005WO2005080367A1 Ep2 receptor agonists
09/01/2005WO2005080363A1 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
09/01/2005WO2005080361A1 Histamine-3 receptor modulators
09/01/2005WO2005080356A1 Tetrazole compounds and their use as metabotropic glutamate receptor antagonits
09/01/2005WO2005080352A2 Quinazoline derivatives and therapeutic use thereof
09/01/2005WO2005080350A1 Pyrimidine derivatives as cannabinoid receptor modulators
09/01/2005WO2005080346A1 Substituted azole derivatives, compositions, and methods of use
09/01/2005WO2005080344A1 Substituted azole compounds and thereof preparation and application
09/01/2005WO2005080343A2 3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators
09/01/2005WO2005080342A1 Pyridine derivatives and their use as cb2 receptor modulators
09/01/2005WO2005080334A1 Novel heterocyclic compound
09/01/2005WO2005080318A1 PROCESSES FOR PRODUCTION OF α-AMINOOXYKETONES AND α-HYDROXYKETONES
09/01/2005WO2005079808A1 Triazole derivatives which inhibit vasopressin antagonistic activity
09/01/2005WO2005079802A1 Bipyridyl amides as modulators of metabotropic glutamate receptor-5
09/01/2005WO2005079801A1 Pyrimidine compounds as purine receptor antagonist
09/01/2005WO2005079800A1 Pyrimidine compounds as purine receptor antagonist
09/01/2005WO2005079799A1 4-acyl-piperazines as anti-viral agents
09/01/2005WO2005079798A1 Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides
09/01/2005WO2005079791A1 Thiophene -2- carboxylic acid - (1h - benzimidazol - 2 yl) - amide derivatives and related compounds as inhibitors of the tec kinase itk (interleukin -2- inducible t cell kinase) for the treatment of inflammation, immunological and allergic disorders
09/01/2005WO2005079790A1 Imidazole-based hmg-coa reductase inhibitors
09/01/2005WO2005070133A3 2,6-disubstituted piperidines as modulators of chemokine receptor activity
09/01/2005WO2005042533A3 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors
09/01/2005WO2005037271A3 Large conductance calcium-activated k channel opener
09/01/2005WO2005021523A8 Piperazine substituted compounds used as calcium channel blockers
09/01/2005US20050192438 to replace the fragile proteinaceous ion pores currently used for studying DNA translocation; 1,4-bis(4-ethynylpyridine)benzene complexed with bis(trioctylphosphino)-platinum(II)bis(trifluoromethanesulphonate)
09/01/2005US20050192339 Compounds
09/01/2005US20050192332 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same
09/01/2005US20050192331 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
09/01/2005US20050192330 Using 4-imidazoline carboxylic acid or ester; antiinflammatory agents; microbiocides; bactericides; antitumor agenst0
09/01/2005US20050192316 Aryl aniline beta2 adrenergic receptor agonists
09/01/2005US20050192307 Benzimidazolone compounds
09/01/2005US20050192305 4-[[4-[(2,6-dichloro-phenyl)methyl]-6-[[2-(1-pyrrolidinyl)ethyl]amino]-2-pyrimidinyl]amino]benzonitrile; 4-[[4-[(2,4,6-trimethylphenyl)amino]-2-pyrimidinyl]amino]benzamide, N1-oxide; viricides; from intermediates; treating AIDS
09/01/2005US20050192304 Rho-kinase inhibitors
09/01/2005US20050192302 3-Cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
09/01/2005US20050192298 Anticarcinogenic agent; useful for producing salts and complexes, impart stability when emplyoyed as drug in the form of tablet or capsule
09/01/2005US20050192297 melanocortin-4 receptor (MC4-R) agonists; antidiabetic agents; non-insulin dependent diabetes; obesity
09/01/2005US20050192294 Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
09/01/2005US20050192293 Vanilloid receptor VR1 modulators; pain, inflammation, traumatic injury, autoimmune disease; compounds are pyridine subsituted at 2 position with an amido-, sulfoamido- or thioamide-substituted (N-hetero)aryl ring
09/01/2005US20050192292 Pyrrolidone carboxamides
09/01/2005US20050192291 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
09/01/2005US20050192287 Substituted benzazoles and methods of their use as inhibitors of Raf kinase
09/01/2005US20050192286 Ligands of melanocortin receptors and compositions and methods related thereto
09/01/2005US20050192284 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processed for its manufacture and its use
09/01/2005US20050192280 Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
09/01/2005US20050192279 Pyridazinones as antagonists of alpha4 integrins
1 ... 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 ... 1080